Recent Finacing
Recent Raise
Amporin Pharmaceuticals develops small-molecule drugs that block and eliminate toxic soluble oligomers and membrane-puncturing pores, aiming to develop and license acute oral disease-modifying treatments starting with Parkinson's and ALS.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor